Precipio (NASDAQ:PRPO) Share Price Passes Above Two Hundred Day Moving Average – Time to Sell?

Precipio, Inc. (NASDAQ:PRPO)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.30 and traded as high as $10.74. Precipio shares last traded at $10.14, with a volume of 77,637 shares.

Precipio Stock Up 5.2 %

The business has a 50-day moving average of $6.42 and a 200-day moving average of $6.30. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.73. The stock has a market capitalization of $15.01 million, a price-to-earnings ratio of -5.54 and a beta of 1.42.

Institutional Trading of Precipio

An institutional investor recently bought a new position in Precipio stock. Renaissance Technologies LLC bought a new stake in shares of Precipio, Inc. (NASDAQ:PRPO) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 10,100 shares of the biotechnology company’s stock, valued at approximately $56,000. Renaissance Technologies LLC owned 0.68% of Precipio at the end of the most recent reporting period. 10.45% of the stock is currently owned by hedge funds and other institutional investors.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.